We are analyzing https://link.springer.com/article/10.1007/s10753-020-01290-1.

Title:
A Spotlight on the Underlying Activation Mechanisms of the NLRP3 Inflammasome and its Role in Atherosclerosis: A Review | Inflammation
Description:
The world’s number one cause of death is cardiovascular diseases. The pathogenesis of different disease entities in the cardiovascular disease spectrum is complicated and multifactorial. Inflammation in these complicated etiologies serves as a key position and is a significant cause of atherosclerosis, which contributes to the underlying pathology. Therefore, therapeutic targeting of inflammatory pathways in patients with cardiovascular diseases such as atherosclerosis enhances cardiovascular results. Inflammasomes are intracellular protein complexes engaged in atherosclerosis pathogenesis and activated by multiple danger signals. Emerging proof has revealed that Nod-like receptor protein 3 (NLRP3) inflammasome, which regulates caspase-1 activation and later pro-interleukin processing, triggers inflammatory reactions in the vascular wall and leads to atherosclerotic plaque formation. Inflammasome-mediated signaling interference could decrease inflammation and mitigate illness severity. In this section, we provide an overview of the present literature on the underlying mechanisms leading to the activation of NLRP3 inflammasome and the role of NLRP3 inflammasome in the progression of atherogenesis and highlight the possibility of therapeutic interventions due to mechanisms involved in the of inhibition of NLRP3 activation.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Health & Fitness
Telecommunications

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

article, pubmed, google, scholar, cas, nlrp, inflammasome, activation, atherosclerosis, central, cell, inflammation, wang, inflammasomes, immunol, mechanisms, role, cardiovascular, caspase, access, nature, nat, biol, cholesterol, privacy, essential, cookies, content, signaling, fitzgerald, inhibits, efflux, yang, springer, chen, crystals, res, information, publish, search, underlying, review, liaqat, diseases, disease, vascular, atherogenesis, endothelial, bauernfeind, expression,

Topics {✒️}

sr/er–mitochondrial local communication month download article/chapter il-1β secretion clics-dependent chloride efflux suppressing ox-ldl uptake myocardial ischemia/reperfusion injury inflammasome-mediated signaling interference monocyte-endothelial cell interactions rna-binding protein tristetraprolin jak1/stat signaling pathway caspase-8 mediate priming article inflammation aims regulates caspase-1 activation full article pdf nitric oxide inhibits cardiovascular disease spectrum apoe-deficient mice crystal-induced activation privacy choices/manage cookies nicotine promotes atherosclerosis nlrp3 inflammasome activity caspase-1-sirtuin 1 pathway nlrp3 inflammasome activation pro-interleukin processing additional information publisher nlrp3 inflammasome expression atherosclerotic plaque formation ldlr−/− mice cxcl16/sr-psox nlrp3 activation downstream promoting cholesterol efflux hyperhomocysteinemia-aggravated inflammation reducing macrophage inflammation dna sensor aim2 stem cell proliferation related subjects nlrp3 inflammasome assembly article liaqat regulating nlrp3 expression noncanonical nlrp3 inflammasomes european economic area mitigate illness severity water influx activate proximal upstream event aluminum salts activate riphah international university authors declare global health burden nucleotide-binding domain underlying activation mechanisms

Questions {❓}

CXCL16/SR-PSOX-A friend or a foe in atherosclerosis?
The NLRP3 inflammasome: A sensor for metabolic danger?
What do we know about the inflammasome in humans?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:A Spotlight on the Underlying Activation Mechanisms of the NLRP3 Inflammasome and its Role in Atherosclerosis: A Review
         description:The world’s number one cause of death is cardiovascular diseases. The pathogenesis of different disease entities in the cardiovascular disease spectrum is complicated and multifactorial. Inflammation in these complicated etiologies serves as a key position and is a significant cause of atherosclerosis, which contributes to the underlying pathology. Therefore, therapeutic targeting of inflammatory pathways in patients with cardiovascular diseases such as atherosclerosis enhances cardiovascular results. Inflammasomes are intracellular protein complexes engaged in atherosclerosis pathogenesis and activated by multiple danger signals. Emerging proof has revealed that Nod-like receptor protein 3 (NLRP3) inflammasome, which regulates caspase-1 activation and later pro-interleukin processing, triggers inflammatory reactions in the vascular wall and leads to atherosclerotic plaque formation. Inflammasome-mediated signaling interference could decrease inflammation and mitigate illness severity. In this section, we provide an overview of the present literature on the underlying mechanisms leading to the activation of NLRP3 inflammasome and the role of NLRP3 inflammasome in the progression of atherogenesis and highlight the possibility of therapeutic interventions due to mechanisms involved in the of inhibition of NLRP3 activation.
         datePublished:2020-07-13T00:00:00Z
         dateModified:2020-07-13T00:00:00Z
         pageStart:2011
         pageEnd:2020
         sameAs:https://doi.org/10.1007/s10753-020-01290-1
         keywords:
            atherosclerosis
            cardiovascular disease
            inflammasome
            inflammation
            interleukin-1β
            Immunology
            Rheumatology
            Pharmacology/Toxicology
            Pathology
            Internal Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-020-01290-1/MediaObjects/10753_2020_1290_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-020-01290-1/MediaObjects/10753_2020_1290_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-020-01290-1/MediaObjects/10753_2020_1290_Fig3_HTML.png
         isPartOf:
            name:Inflammation
            issn:
               1573-2576
               0360-3997
            volumeNumber:43
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Anam Liaqat
               url:http://orcid.org/0000-0002-1849-8455
               affiliation:
                     name:Riphah International University
                     address:
                        name:Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Muhammad Asad
               affiliation:
                     name:National Institute of Heart Diseases
                     address:
                        name:Armed Forces Institute of Cardiology, National Institute of Heart Diseases, Rawalpindi, Pakistan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Fatima Shoukat
               affiliation:
                     name:Riphah International University
                     address:
                        name:Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Arif-Ullah Khan
               affiliation:
                     name:Riphah International University
                     address:
                        name:Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:A Spotlight on the Underlying Activation Mechanisms of the NLRP3 Inflammasome and its Role in Atherosclerosis: A Review
      description:The world’s number one cause of death is cardiovascular diseases. The pathogenesis of different disease entities in the cardiovascular disease spectrum is complicated and multifactorial. Inflammation in these complicated etiologies serves as a key position and is a significant cause of atherosclerosis, which contributes to the underlying pathology. Therefore, therapeutic targeting of inflammatory pathways in patients with cardiovascular diseases such as atherosclerosis enhances cardiovascular results. Inflammasomes are intracellular protein complexes engaged in atherosclerosis pathogenesis and activated by multiple danger signals. Emerging proof has revealed that Nod-like receptor protein 3 (NLRP3) inflammasome, which regulates caspase-1 activation and later pro-interleukin processing, triggers inflammatory reactions in the vascular wall and leads to atherosclerotic plaque formation. Inflammasome-mediated signaling interference could decrease inflammation and mitigate illness severity. In this section, we provide an overview of the present literature on the underlying mechanisms leading to the activation of NLRP3 inflammasome and the role of NLRP3 inflammasome in the progression of atherogenesis and highlight the possibility of therapeutic interventions due to mechanisms involved in the of inhibition of NLRP3 activation.
      datePublished:2020-07-13T00:00:00Z
      dateModified:2020-07-13T00:00:00Z
      pageStart:2011
      pageEnd:2020
      sameAs:https://doi.org/10.1007/s10753-020-01290-1
      keywords:
         atherosclerosis
         cardiovascular disease
         inflammasome
         inflammation
         interleukin-1β
         Immunology
         Rheumatology
         Pharmacology/Toxicology
         Pathology
         Internal Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-020-01290-1/MediaObjects/10753_2020_1290_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-020-01290-1/MediaObjects/10753_2020_1290_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-020-01290-1/MediaObjects/10753_2020_1290_Fig3_HTML.png
      isPartOf:
         name:Inflammation
         issn:
            1573-2576
            0360-3997
         volumeNumber:43
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Anam Liaqat
            url:http://orcid.org/0000-0002-1849-8455
            affiliation:
                  name:Riphah International University
                  address:
                     name:Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Muhammad Asad
            affiliation:
                  name:National Institute of Heart Diseases
                  address:
                     name:Armed Forces Institute of Cardiology, National Institute of Heart Diseases, Rawalpindi, Pakistan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Fatima Shoukat
            affiliation:
                  name:Riphah International University
                  address:
                     name:Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Arif-Ullah Khan
            affiliation:
                  name:Riphah International University
                  address:
                     name:Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Inflammation
      issn:
         1573-2576
         0360-3997
      volumeNumber:43
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Riphah International University
      address:
         name:Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan
         type:PostalAddress
      name:National Institute of Heart Diseases
      address:
         name:Armed Forces Institute of Cardiology, National Institute of Heart Diseases, Rawalpindi, Pakistan
         type:PostalAddress
      name:Riphah International University
      address:
         name:Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan
         type:PostalAddress
      name:Riphah International University
      address:
         name:Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Anam Liaqat
      url:http://orcid.org/0000-0002-1849-8455
      affiliation:
            name:Riphah International University
            address:
               name:Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Muhammad Asad
      affiliation:
            name:National Institute of Heart Diseases
            address:
               name:Armed Forces Institute of Cardiology, National Institute of Heart Diseases, Rawalpindi, Pakistan
               type:PostalAddress
            type:Organization
      name:Fatima Shoukat
      affiliation:
            name:Riphah International University
            address:
               name:Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan
               type:PostalAddress
            type:Organization
      name:Arif-Ullah Khan
      affiliation:
            name:Riphah International University
            address:
               name:Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan
      name:Armed Forces Institute of Cardiology, National Institute of Heart Diseases, Rawalpindi, Pakistan
      name:Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan
      name:Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(208)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

4.08s.

LINK . SPRINGER . COM {}